Sorry, you need to enable JavaScript to visit this website.
Skip to main content

This site is intended only for healthcare professionals resident in the United Kingdom

Pfizer Ltd offers a diverse portfolio of medicines across a broad range of therapeutic areas and is committed to supporting the appropriate use of these medicines in patients. Join us at one of our promotional virtual meetings to learn more.

The promotional meetings below are organised and funded by Pfizer and may include reference to Pfizer medicines relevant to agenda topics. Prescribing information for the relevant medicine can be found underneath the meeting information. Adverse event reporting information can be found at the bottom of the page.


Live webinars

Filter By Therapeutic Areas:
NVAF
Cardiology
Duration
1 Hr 45
20
Sep
2021
19:00
  • ELIQUIS®(apixaban) - NVAF
PP-ELI-GBR-9384. July 2021

Common Clinical Challenges in Anti-Coagulation - NICE Non-Valvular Atrial Fibrillation 2021 Update

Dr Derek Connolly Dr Melanie Martins
Suggested audience
Consultants
General Practitioners
Nurses
Pharmacists
Specialist Registrars
Read more Register Here

ELIQUIS®(apixaban) Prescribing Information and Adverse Event Reporting

Risk Minimisation Materials:
Eliquis Prescriber Guide and Patient Alert Card are aimed at increasing awareness about the potential risk of bleeding with apixaban.
More information on each of these documents can be found at
www.medicines.org.uk/emc/product/2878/rmms (5 mg)
or www.medicines.org.uk/emc/product/4756/rmms (2.5 mg).

NVAF
Duration
1 Hr 15
21
Sep
2021
09:00
  • ELIQUIS®(apixaban) - NVAF
PP-ELI-GBR-9552. August 2021

Implementing the new NICE Guidance 2021: Stroke Prevention in NVAF

Dr John Bright
Suggested audience
Consultants
General Practitioners
Nurses
Pharmacists
Specialist Registrars
Read more Register Here

ELIQUIS®(apixaban) Prescribing Information and Adverse Event Reporting

Risk Minimisation Materials:
Eliquis Prescriber Guide and Patient Alert Card are aimed at increasing awareness about the potential risk of bleeding with apixaban.
More information on each of these documents can be found at
www.medicines.org.uk/emc/product/2878/rmms (5 mg)
or www.medicines.org.uk/emc/product/4756/rmms (2.5 mg).

VTE
Duration
1 Hr
21
Sep
2021
13:00
  • ELIQUIS®(apixaban) - VTE
PP-ELI-GBR-9555. August 2021

VTE Management in The Frail Elderly Patient

Dr Darshan Hanumanth Kumar Dr Laura Crowley
Suggested audience
Consultants
General Practitioners
Nurses
Pharmacists
Specialist Registrars
Read more Register Here

ELIQUIS® (apixaban) Prescribing Information and Adverse Event Reporting

Risk Minimisation Materials:
Eliquis Prescriber Guide and Patient Alert Card are aimed at increasing awareness about the potential risk of bleeding with apixaban.
More information on each of these documents can be found at
www.medicines.org.uk/emc/product/2878/rmms (5 mg)
or www.medicines.org.uk/emc/product/4756/rmms (2.5 mg).

NVAF
VTE
Cardiology
Gastroenterology
Haematology
Haem Oncology
Rheumatology
Vaccines
Duration
1 Hr
22
Sep
2021
13:00
  • ELIQUIS®(apixaban) - NVAF & VTE
PP-ELI-GBR-9299. July 2021

Venous Thromboembolism: Long-term Treatment & Prevention of Recurrence

Professor Azfar Zaman
Suggested audience
Consultants
General Practitioners
Nurses
Pharmacists
Specialist Registrars
Read more Register Here

ELIQUIS® (apixaban) Prescribing Information and Adverse Event Reporting

Risk Minimisation Materials:
Eliquis Prescriber Guide and Patient Alert Card are aimed at increasing awareness about the potential risk of bleeding with apixaban.
More information on each of these documents can be found at
www.medicines.org.uk/emc/product/2878/rmms (5 mg)
or www.medicines.org.uk/emc/product/4756/rmms (2.5 mg).

NVAF
Cardiology
Duration
1 Hr
23
Sep
2021
13:00
  • ELIQUIS®(apixaban) - NVAF
  • Vyndaqel(tafamidis)
PP-INT-GBR-0356. July 2021

Cardiology Update Meeting

Dr Oliver Watson Dr Nigel Lewis
Suggested audience
Consultants
General Practitioners
Nurses
Pharmacists
Specialist Registrars
Read more Register Here

ELIQUIS®(apixaban) Prescribing Information and Adverse Event Reporting

Risk Minimisation Materials:
Eliquis Prescriber Guide and Patient Alert Card are aimed at increasing awareness about the potential risk of bleeding with apixaban.
More information on each of these documents can be found at
www.medicines.org.uk/emc/product/2878/rmms (5 mg)
or www.medicines.org.uk/emc/product/4756/rmms (2.5 mg).

Vyndaqel(tafamidis) Prescribing Information and Adverse Event Reporting

Cardiology
NVAF
VTE
Other
Duration
1 Hr 10
23
Sep
2021
18:00
  • ELIQUIS®(apixaban) - NVAF & VTE
PP-ELI-GBR-9565. August 2021

NVAF & Renal Patients and Other Renal Issues from Primary and Secondary Care

Dr Timothy Shipley
Suggested audience
Consultants
General Practitioners
Nurses
Pharmacists
Specialist Registrars
Read more Register Here

ELIQUIS® (apixaban) Prescribing Information and Adverse Event Reporting

Risk Minimisation Materials:
Eliquis Prescriber Guide and Patient Alert Card are aimed at increasing awareness about the potential risk of bleeding with apixaban.
More information on each of these documents can be found at
www.medicines.org.uk/emc/product/2878/rmms (5 mg)
or www.medicines.org.uk/emc/product/4756/rmms (2.5 mg).

NVAF
Cardiology
Endocrine
Gastroenterology
Haematology
Duration
1 Hr 5
29
Sep
2021
12:25
29
Sep
2021
19:25
  • ELIQUIS®(apixaban) - NVAF
PP-ELI-GBR-9546. August 2021

Hitting the Trifecta: Optimal Management of the NVAF, Diabetic, Heart Failure Patient

Dr Rob Skelly
Suggested audience
Consultants
General Practitioners
Nurses
Pharmacists
Specialist Registrars
Read more Register Here

ELIQUIS®(apixaban) Prescribing Information and Adverse Event Reporting

Risk Minimisation Materials:
Eliquis Prescriber Guide and Patient Alert Card are aimed at increasing awareness about the potential risk of bleeding with apixaban.
More information on each of these documents can be found at
www.medicines.org.uk/emc/product/2878/rmms (5 mg)
or www.medicines.org.uk/emc/product/4756/rmms (2.5 mg).

NVAF
Cardiology
Duration
1 Hr
30
Sep
2021
13:00
  • ELIQUIS®(apixaban) - NVAF
PP-ELI-GBR-9398. July 2021

Anticoagulation in Specific Circumstances - Renal Dysfunction, Elderly, the Obese Patient and ACS

Angela Hall
Suggested audience
Nurses
Read more Register Here

ELIQUIS®(apixaban) Prescribing Information and Adverse Event Reporting

Risk Minimisation Materials:
Eliquis Prescriber Guide and Patient Alert Card are aimed at increasing awareness about the potential risk of bleeding with apixaban.
More information on each of these documents can be found at
www.medicines.org.uk/emc/product/2878/rmms (5 mg)
or www.medicines.org.uk/emc/product/4756/rmms (2.5 mg).

NVAF
Cardiology
Duration
1 Hr
30
Sep
2021
13:00
  • ELIQUIS®(apixaban) - NVAF
PP-ELI-GBR-9305. July 2021

Cardiology Update Meeting

Dr Fiona Carr Dr Andrew McCoye
Suggested audience
Consultants
General Practitioners
Nurses
Pharmacists
Specialist Registrars
Read more Register Here

ELIQUIS®(apixaban) Prescribing Information and Adverse Event Reporting

Risk Minimisation Materials:
Eliquis Prescriber Guide and Patient Alert Card are aimed at increasing awareness about the potential risk of bleeding with apixaban.
More information on each of these documents can be found at
www.medicines.org.uk/emc/product/2878/rmms (5 mg)
or www.medicines.org.uk/emc/product/4756/rmms (2.5 mg).

NVAF
VTE
Duration
1 Hr
30
Sep
2021
19:30
  • ELIQUIS®(apixaban) - NVAF & VTE
PP-ELI-GBR-9461. August 2021

Dilemmas in Anticoagulation: Extremes of Body Weight and Renal Function

Dr Michael Jackson Mr Nathan Hutchinson-Jones
Suggested audience
Pharmacists
Read more Register Here

ELIQUIS® (apixaban) Prescribing Information and Adverse Event Reporting

Risk Minimisation Materials:
Eliquis Prescriber Guide and Patient Alert Card are aimed at increasing awareness about the potential risk of bleeding with apixaban.
More information on each of these documents can be found at
www.medicines.org.uk/emc/product/2878/rmms (5 mg)
or www.medicines.org.uk/emc/product/4756/rmms (2.5 mg).

NVAF
Duration
1 Hr 30
05
Oct
2021
19:00
  • ELIQUIS®(apixaban) - NVAF
PP-ELI-GBR-9634. September 2021

Geriatric Giants 2

Dr James Read
Suggested audience
General Practitioners
Nurses
Pharmacists
Read more Register Here

ELIQUIS®(apixaban) Prescribing Information and Adverse Event Reporting

Risk Minimisation Materials:
Eliquis Prescriber Guide and Patient Alert Card are aimed at increasing awareness about the potential risk of bleeding with apixaban.
More information on each of these documents can be found at
www.medicines.org.uk/emc/product/2878/rmms (5 mg)
or www.medicines.org.uk/emc/product/4756/rmms (2.5 mg).

NVAF
Cardiology
Duration
1 Hr
13
Oct
2021
18:00
  • ELIQUIS®(apixaban) - NVAF
PP-ELI-GBR-9553. August 2021

Arrhythmias and When to Refer

Jayne Mudd
Suggested audience
Consultants
General Practitioners
Nurses
Pharmacists
Specialist Registrars
Read more Register Here

ELIQUIS®(apixaban) Prescribing Information and Adverse Event Reporting

Risk Minimisation Materials:
Eliquis Prescriber Guide and Patient Alert Card are aimed at increasing awareness about the potential risk of bleeding with apixaban.
More information on each of these documents can be found at
www.medicines.org.uk/emc/product/2878/rmms (5 mg)
or www.medicines.org.uk/emc/product/4756/rmms (2.5 mg).

NVAF
Cardiology
Duration
1 Hr 15
14
Oct
2021
19:30
  • ELIQUIS®(apixaban) - NVAF
PP-ELI-GBR-9656. September 2021

Managing Atrial Fibrillation: Implementing new NICE Guidance in a Virtual World

Ms Jayne Mudd
Suggested audience
General Practitioners
Nurses
Pharmacists
Other (HCP)
Read more Register Here

ELIQUIS®(apixaban) Prescribing Information and Adverse Event Reporting

Risk Minimisation Materials:
Eliquis Prescriber Guide and Patient Alert Card are aimed at increasing awareness about the potential risk of bleeding with apixaban.
More information on each of these documents can be found at
www.medicines.org.uk/emc/product/2878/rmms (5 mg)
or www.medicines.org.uk/emc/product/4756/rmms (2.5 mg).

NVAF
Duration
1 Hr 20
14
Oct
2021
19:30
  • ELIQUIS®(apixaban) - NVAF
PP-ELI-GBR-9573. August 2021

How Can I Improve NVAF Detection and Therapy?

Dr Chris Hayes Stephen Doyle
Suggested audience
General Practitioners
Nurses
Pharmacists
Specialist Registrars
Read more Register Here

ELIQUIS®(apixaban) Prescribing Information and Adverse Event Reporting

Risk Minimisation Materials:
Eliquis Prescriber Guide and Patient Alert Card are aimed at increasing awareness about the potential risk of bleeding with apixaban.
More information on each of these documents can be found at
www.medicines.org.uk/emc/product/2878/rmms (5 mg)
or www.medicines.org.uk/emc/product/4756/rmms (2.5 mg).

NVAF
Cardiology
Duration
1 Hr
20
Oct
2021
18:00
  • ELIQUIS®(apixaban) - NVAF
PP-ELI-GBR-9554. August 2021

Palpitations and When to Refer

Jayne Mudd
Suggested audience
Consultants
General Practitioners
Nurses
Pharmacists
Specialist Registrars
Read more Register Here

ELIQUIS®(apixaban) Prescribing Information and Adverse Event Reporting

Risk Minimisation Materials:
Eliquis Prescriber Guide and Patient Alert Card are aimed at increasing awareness about the potential risk of bleeding with apixaban.
More information on each of these documents can be found at
www.medicines.org.uk/emc/product/2878/rmms (5 mg)
or www.medicines.org.uk/emc/product/4756/rmms (2.5 mg).

NVAF
Cardiology
Duration
1 Hr
21
Oct
2021
13:00
  • ELIQUIS®(apixaban) - NVAF
PP-ELI-GBR-9399. July 2021

Remote and Digital Applications for Arrhythmia Monitoring

Angela Hall
Suggested audience
Nurses
Read more Register Here

ELIQUIS®(apixaban) Prescribing Information and Adverse Event Reporting

Risk Minimisation Materials:
Eliquis Prescriber Guide and Patient Alert Card are aimed at increasing awareness about the potential risk of bleeding with apixaban.
More information on each of these documents can be found at
www.medicines.org.uk/emc/product/2878/rmms (5 mg)
or www.medicines.org.uk/emc/product/4756/rmms (2.5 mg).

NVAF
Cardiology
Duration
1 Hr 30
21
Oct
2021
19:10
  • ELIQUIS®(apixaban) - NVAF
PP-ELI-GBR-9516. August 2021

An Integrated Care System Approach in Optimising Care for Patients with Non-Valvular Atrial Fibrillation

Zainab Khanbhai Bhupinder Pandya
Suggested audience
General Practitioners
Nurses
Pharmacists
Read more Register Here

ELIQUIS®(apixaban) Prescribing Information and Adverse Event Reporting

Risk Minimisation Materials:
Eliquis Prescriber Guide and Patient Alert Card are aimed at increasing awareness about the potential risk of bleeding with apixaban.
More information on each of these documents can be found at
www.medicines.org.uk/emc/product/2878/rmms (5 mg)
or www.medicines.org.uk/emc/product/4756/rmms (2.5 mg).

FAQ

See if our frequently asked questions solves your query. If not, use our online enquiry form to get in touch

PP-PFE-GBR-3661. May 2021